Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax RateTax Rate
Others
Ratios

Forte Biosciences (FBRX) EPS (Basic) (2016 - 2020)

Forte Biosciences (FBRX) has disclosed EPS (Basic) for 5 consecutive years, with $1.04 as the latest value for Q4 2020.

  • Quarterly EPS (Basic) rose 331.11% to $1.04 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was -$9.9 through Dec 2020, up 98.43% year-over-year, with the annual reading at -$4.71 for FY2025, 61.3% up from the prior year.
  • EPS (Basic) for Q4 2020 was $1.04 at Forte Biosciences, up from -$0.45 in the prior quarter.
  • The five-year high for EPS (Basic) was $1.04 in Q4 2020, with the low at -$330.0 in Q3 2019.
  • Average EPS (Basic) over 5 years is -$33.22, with a median of -$0.88 recorded in 2018.
  • The sharpest move saw EPS (Basic) crashed 1649900.0% in 2019, then surged 331.11% in 2020.
  • Over 5 years, EPS (Basic) stood at -$3.83 in 2016, then surged by 85.64% to -$0.55 in 2017, then plummeted by 74.55% to -$0.96 in 2018, then surged by 53.12% to -$0.45 in 2019, then soared by 331.11% to $1.04 in 2020.
  • According to Business Quant data, EPS (Basic) over the past three periods came in at $1.04, -$0.45, and -$9.52 for Q4 2020, Q3 2020, and Q2 2020 respectively.